We investigated the immunohistochemical characteristics of 13 cases of odontogenic carcinoma, including 3 cases of ameloblastic carcinoma, 9 cases of primary intraosseous squamous cell carcinoma (PIOSCC), and 1 case of ghost cell odontogenic carcinoma (GCOC), to elucidate the origin and determine diagnostic markers of odontogenic carcinoma. Thirty cases of gingival squamous cell carcinoma (gSCC) were included for comparison. All ameloblastic carcinomas and GCOC cases, as well as 6 of 9 PIOSCC cases, exhibited immunoreactivity for CK19, whereas only 3 of 30 gSCC cases were positive for CK19. Two cases of ameloblastic carcinoma and only 1 case of PIOSCC expressed CD56; however, CD56 was not expressed in any gSCC cases. All odontogenic carcinoma cases except a single GCOC case were negative for calretinin. These findings indicate that immunoreactivity to CK19 is useful to identify odontogenic origin of the odontogenic carcinomas including PIOSCC, and it may also be useful for distinguishing PIOSCC from gSCC.
Introduction
Odontogenic carcinomas are rare tumors which arise within the jaws, and they presumably originate from epithe lial remnants of odontogenesis that include the periradicular rests of Malassez, the reduced enamel epithelium surrounding the impacted tooth, and the dental lamina (12) or from transformation of benign odontogenic tumors or cysts (35) . The 2005 World Health Organization (WHO) histological classification of odontogenic tumors divides odontogenic carcinomas into 5 types: 1) metastasizing ameloblastoma, 2) ameloblastic carcinoma, 3) primary intraosseous squamous cell carcinoma (PIOSCC), 4) clear cell odontogenic carcinoma, and 5) ghost cell odontogenic carcinoma (GCOC) (6) .
Among these, PIOSCC is histologically characterized by islands of neoplastic squamous cell epithelium with features of squamous cell carcinoma (SCC). PIOSCC is divided into 3 categories: a) PIOSCC-solid type, b) PIOSCC derived from keratocystic odontogenic tumor (KCOT), and c) PIOSCC derived from odontogenic cysts (OC) (6) . In PIOSCC-solid type, a solid tumor develops in the jaws without evidence of originating from KCOT or OC. The important differential diagnoses of PIOSCCsolid type include metastatic SCC and SCC originating from the gingival mucosa. Though some PIOSCC have odontogenic pattern with palisading of peripheral cells of the tumor nests, there are usually no specific histopathological features that distinguish the latter two SCCs from PIOSCC (6) . Therefore, it may be difficult to distinguish gingival SCC (gSCC) from PIOSCC when PIOSCC destroys the cortex of the jaw and merges with surface mucosa. To address these issues, the characteristics of PIOSCC, particularly solid type, need to be better elucidated.
Immunohistochemical studies provide important information to determine the histogenesis and diagnostic markers for specific tumors, including odontogenic tumors. Cytokeratin 19 (CK19) is expressed in ameloblastomas, calcifying epithelial odontogenic tumors, adenomatoid odontogenic tumors, and calcifying cystic odontogenic tumors as well as in dentigerous cysts and radicular cysts (711). In addition, epithelial cells in enamel organs and dental lamina express CK19 (9, 10, 12) . These findings suggest that CK19 is one possible marker for cells of odontogenic origin and may be useful for diagnosis of odontogenic tumors. Recent studies have suggested that CD56 (also known as neural cell adhesion molecule, NCAM) and calretinin are useful for investigating the histogenesis and diagnosis of odontogenic tumors (13) (14) (15) (16) (17) (18) (19) . Thus, immunohistochemistry has been successfully applied to investigate odontogenic tumors; however, these studies were limited mostly to benign odontogenic tumors, except for a few reports on odontogenic carcinomas (10, 20) , most likely due to the low incidence of malignant odontogenic carcinomas.
Therefore, there is a need for immunohistochemical studies on an accumulated number of cases to investigate the characteristics of odontogenic carcinomas. We investigated the immunohistochemical characteristics of 13 cases of odontogenic carcinoma that include 9 cases of PIOSCC, and suggest that CK19 is useful for identifying the odontogenic origin of odontogenic carcinomas and for distinguishing PIOSCC from gSCC.
Materials and methods

Cases
We investigated 13 cases of odontogenic carcinomas in patients who were diagnosed and registered at the Faculty of Dentistry, Tokyo Medical and Dental University Hospital, from 1985 to 2006. Neither radiation therapy nor chemotherapy was administered prior to biopsy or surgical excision. The patients were 11 men and 2 women, with ages ranging from 21 to 72 years, with a mean of 50.8 years (males 51.5 years, females 47.5 years). Tumors were located in the mandible in 10 patients (77%) and in the maxilla in 3 patients (23%). The clinical information is summarized in Table 1 .
The histological diagnosis of odontogenic carcinomas was performed according to the 2005 WHO histological classification of odontogenic tumors (6) . Among the 13 patients, 3 patients had ameloblastic carcinomas; 9 patients had PIOSCC (6 PIOSCC-solid type, 2 PIOSCC derived from KCOT, 1 PIOSCC derived from OC); and 1 patient had a GCOC. In all 9 cases of PIOSCC, the tumors were located in the center of the jaw bone, and they replaced the jaw bone with destruction of the cortex. Suei et al. have proposed the following criteria for the diagnosis of PIOSCC: 1) no ulcer formation on the overlying oral mucosa except that due to tooth extraction, and 2) absence of another primary tumor at the time of diagnosis and throughout a followup period of more than 6 months (21) . Eight cases of 9 PIOSCC met these criteria. Though one case (case 10) had a small ulcer on the overlying oral mucosa due to invasion of the carcinoma in the operative material, no ulcerative lesion was observed at first clinical examination. Histologically, dysplasia or carcinoma was not observed in the covering epithelium adjacent to the ulcer. Furthermore, the carcinoma cells showed transition to the non-carcinomatous keratinizing squamous epithelium which covered the cystic wall. Based on these findings, we classified this case as PIOSCC derived from KCOT. We included 3 cases of ameloblastoma (1 case of follicular variant, 1 case of follicular to plexiform variant, and 1 case of plexiform variant) and 30 cases of gSCC (10 cases each of well differentiated type, moderately differentiated type, and poorly differentiated type) to compare the immunoreactivities of odontogenic carcinomas with those of other tumors. None of the gSCC patients had previously received radiation therapy or chemotherapy. The gSCC patients were 17 men and 13 women, with ages ranging from 51 to 80 years, with a mean of 66.4 years (male 67.2 years, females 65.4 years). The tumor sites were the left maxilla (4 cases), the right maxilla (5 cases), the left mandible (12 cases), and the right mandible (9 cases). The clinical information of the patients with ameloblastomas and gSCCs is summarized in Table 2 .
Histopathological analyses
Histopathological analysis was conducted using specimens obtained from biopsy and operative materials. The specimens were fixed in 10% buffered formalin and then embedded in paraffin. Some specimens were decalcified in Plank-Rychlo solution. Paraffin sections of 4 μm thickness were cut and stained with hematoxylin and eosin (HE).
Immunohistochemical analyses
For immunohistochemical staining, non-decalcified sections prepared from biopsy or operative materials were used. Immunohistochemical staining was performed by the standard streptavidin-biotinylated immunoperoxidase (SAB) method using the Histofine SAB-PO kit (Nichirei Co., Ltd., Tokyo, Japan). The primary antibodies were CK19 (b170, 1:100; Novocastra Laboratories, Newcastle, UK), CD56 (1B6, 1:100; Novocastra), and calretinin (polyclonal, 1:4; Zymed Laboratories, South San Francisco, CA, USA). After deparaffinization and rehydration, antigen retrieval was carried out 0.1% in trypsin phosphate-buffered saline (PBS) for 20 minutes at room temperature for CK19. The antigen retrieval for CD56 or calretinin was carried out by autoclaving at 121℃ for 15 minutes in 10 mM citrate buffer (pH 6.0). Endogenous peroxidase activity was blocked by immersing the slides for 30 minutes in methanol containing 0.3% H2O2, and the slides were then incubated with primary antibodies in a moist chamber and kept in a refrigerator overnight. For color development, the slides were immersed in 3,3ʼ-diamino-benzidine solution and counterstained with hematoxylin. Negative control sections were treated with PBS instead of primary antibodies.
Immunoreactivity scores were assigned according to semi-quantitative visual estimation of the number of reactive tumor cells out of the total number of cells in the areas. More than 1,000 tumor cells were examined in at least 3 areas. Immunoreactivity was scored as negative or positive. The absence of immunopositive cells was graded as negative (score 0). The positive cases were classified into 3 grades depending on the percentage of positive tumor cells in all tumor cells as follows: 1+, 1-10%; 2+, 11-50%; 3+, 51100%. The grading was performed based on the number of positive cells, regardless of intensity.
Statistical analyses
Fisherʼs exact probability test was used to compare the immunohistochemical expression among different cases. P-values <0.05 were considered to be statistically significant.
Results
Histopathology of odontogenic carcinomas
We investigated 13 cases of odontogenic carcinoma that included 3 cases of ameloblastic carcinoma, 9 cases of PIOSCC, and one case of GCOC. Table 3 summarizes the histopathological characteristics of these tumors.
Ameloblastic carcinoma (cases 13): All cases of ameloblastic carcinoma retained the histological features of ameloblastoma. Epithelial islands exhibited peripheral palisading and inverted nuclear polarity, i.e., polarization of the nuclei away from the basement membrane. The tumors showed high cellularity, cellular atypia, and increased mitotic activity. In 2 cases (case 1 and case 2), the tumors exhibited stellate reticulum-like structures and squamous metaplastic cells at the center of the tumor nests ( Fig. 1a) . In case 3, the tumor cells formed anastomosing cords and trabeculae associated with inverted nuclear polarity, but stellate reticulum-like structures were not apparent.
PIOSCC (cases 412): PIOSCC cases consisted of 6 cases of PIOSCC-solid type (cases 4-9), 2 cases of PIOSCC derived from KCOT (cases 10, 11), and 1 case of PIOSCC derived from OC (case 12). There were no findings that indicated as extra-osseous origin in PIOSCC cases. Based on the histological grading of SCC, the PIOSCCsolid types were well differentiated ( Fig. 2a ), moderately differentiated, and poorly differentiated in 2, 3, and 1 cases, respectively. PIOSCC derived from KCOT was moderately differentiated, and poorly differentiated ( Fig. 3a ) each in a single case. The PIOSCC derived from OC was moderately differentiated. Four cases of PIOSCC exhibited no apparent odontogenic features (3 cases of PIOSCCsolid type and the PIOSCC derived from OC), while 5 cases (3 cases of PIOSCC-solid type, 2 cases of PIOSCC derived from KCOT) showed an odontogenic pattern with palisading of the peripheral cells in some tumor nests, but lacked the inverted nuclear polarity and stellate reticulum-like structures of ameloblastic carcinoma. In 5 cases (3 cases of PIOSCCsolid type, 1 case of PIOSCC derived from KCOT and the PIOSCC derived from OC), the tumors were associated with impacted teeth.
GCOC (case 13): This tumor occurred approximately 4 years after enucleation of calcifying cystic odontogenic tumor (CCOT). Histologically, the tumor was solid and composed of relatively large polygonal or oval cells with high N/C ratios. Nuclei were hyperchromatic and poorly developed nucleoli were observed. Cellular atypia was evident with increased mitotic activity. Multi-nucleated giant cells were frequently noted. Tumor cells formed solid nests or ribbons with scattered ghost cells (Fig. 4a ). The tumor contained small cystic lesions focally corresponding to a benign CCOT component. Neither dentinoid nor calcification was present. Tables 3 and 4 summarize the immunohistochemical results of all cases. Scoring was performed as described above.
Immunohistochemical profiles
Ameloblastoma: All cases of ameloblastoma were positive for CK19 (score 3+). Almost all stellate reticulumlike cells in the inner portion and some outermost cells in the follicular or plexiform tumor nests showed CK19 immunoreactivity (Fig. 5b) . Tumor cells in all cases exhibited immunoreactivity to CD56. In the case of follicular variant and in the case of follicular to plexiform variant, immunopositive cells were usually located in the outermost layers of the follicular tumor nests (score 3+; Fig. 5c ). In the plexiform ameloblastoma, some of the inner cells or outermost cells of the nests exhibited CD56 immunoreactivity (score 1+). Positive staining for calretinin was observed in 2 cases (follicular variant, score 2+; Fig. 5d ; follicular to plexiform variant, score 1+). Staining included the nuclei and cytoplasm of the tumor cells and was limited to the inner Peripheral palisading and inverted nuclear polarity were present. Tumor cells showed cellular atypia and increased mitotic activity (a). The tumor showed positive staining for CK19 in the inner squamous metaplastic cells and some of the outermost cells (score 2+) (b). CD56 reactivity was more prominent in the outermost palisading layer than in the inner portion (score 3+) (c). No staining for calretinin was observed (score 0) (d).
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squamous metaplastic cells and to the stellate reticulum. The plexiform variant, which has no stellate reticulum, was negative for calretinin. Ameloblastic carcinoma: All cases of ameloblastic carcinoma were positive for CK19. Two cases (case 2 and case 3) demonstrated diffusely positive staining in most tumor cells (score 3+), while the immunoreactivity was limited to the basal layer cells in the adjacent oral stratified squamous epithelium. Case 1 showed positive staining for CK19 in the inner squamous metaplastic cells and some of the outermost tumor cells (score 2+; Fig. 1b ). CD56 positive cells were observed in case 1 (score 3+) and case 3 (score 1+). In case 1, CD56 reactivity was more prominent in the outermost palisading layer than in the inner portion (Fig.  1c ). All cases of ameloblastic carcinoma were negative for calretinin ( Fig. 1d) .
PIOSCC: Among the 6 cases of PIOSCCsolid type, CK19 positive staining was observed in 4 cases, in which the scores of 3+ and 1+ were observed in 2 cases each and the score 2+ in 1 case (Fig. 2b) . One case of 2 PIOSCC derived from KCOT was immunopositive for CK19 (score 3+ ; Fig.  3b ). The PIOSCC derived from OC demonstrated positive staining for CK19 (score 1+). CD56 was positive in some tumor cells only in 1 case of PIOSCC-solid type (case 9; Almost all tumor cells showed staining for CK19 (score 3+) (b). No staining for CD56 was observed (score 0) (c). No staining for calretinin was observed (score 0) (d).
a b c d score 1+), whereas 2 cases of ameloblastic carcinoma expressed CD56. However, there was no statistically significant difference in the proportion of CD56 expression between ameloblastic carcinoma and PIOSCC (P = 0.13).
All cases of PIOSCC cases were negative for calretinin ( Figs. 2d & 3d) . GCOC: Almost all tumor cells in the GCOC case were positive for CK19 (score 3+; Fig. 4b ). Tumor cells exhibited positive staining for calretinin (score 2+; Fig. 4d ). No staining for CD56 was seen (Fig. 4c) .
gSCC: Among the 30 cases of gSCC, 3 cases (10%) exhibited positive staining for CK19; these 3 cases consisted of moderately or poorly differentiated SCC with scores of 2+ or 3+. All cases were negative for CD56. Two cases of poorly differentiated gSCC (7%) showed positive staining for calretinin (score 2+ and 3+). The difference in the proportion of CK19 expression between PIOSCC and gSCC was statistically significant at P = 0.0017. A statistical difference in the proportion of CD56 expression was found between odontogenic carcinoma and gSCC (P = 0.023), but not between PIOSCC and gSCC (P = 0.23).
Discussion
We investigated 13 cases of odontogenic carcinoma that were diagnosed in accordance with the 2005 WHO histological classification of odontogenic tumors. We analyzed each case for expression of CK19, CD56, and calretinin. Cytokeratins (CKs) are intermediate filaments that function as the epithelial cytoskeleton and can be classified into 20 different types according to the physicochemical characteristics of the polypeptides (22) . Different sets of CKs are expressed in various epithelia or carcinomas (23) . CK19 has a molecular weight of 40 kDa (22) and shows immunoreactivity to basal cells in gingival stratified squamous epithelium (24) . Several studies have shown that immunohistochemistry of CK19 is useful for identification of odontogenic tumors as various odontogenic epithelia also express CK19 (7) (8) (9) (10) (11) (12) ; however, these studies were limited to benign odontogenic tumors. To determine the usefulness of CK19 for diagnosis of odontogenic carcinomas, we investigated the immunoreactivity of CK19 in 13 cases of odontogenic carcinoma. Our study confirmed that ameloblastoma is positive for CK19, as previously reported (9) (10) . Of the 13 cases of odontogenic carcinoma, all ameloblastic carcinomas (3 cases), 6 of 9 cases of PIOSCC, and a single case of GCOC case exhibited immunoreactivity to CK19. These results indicate that immunoreactivity to CK19 is retained in most odontogenic carcinomas, and suggest it has some specificity for identifying the odontogenic origin of the tumors. Although the basal cells in normal oral mucosa express CK19, the immunoreactivity of CK19 in oral SCC has remained debatable, ranging from 29% to 91% depending on the studies reported using a small number of cases (25) . We investigated 30 cases of gSCC, of which only 3 cases (10%) were positive for CK19. The difference in the degree of CK19 expression between PIOSCC and gSCC was statistically significant. This finding also suggests that CK19 is useful for distinguishing PIOSCC from gSCC. CD56 (NCAM) is a 140-kDa transmembrane protein, belonging to the immunoglobulin superfamily and is expressed by a variety of neuronal cells and non-neuronal tissues, including natural killer cells, subsets of T lymphocytes, the cortices of the central nervous system, neuromuscular junction, and various neuroendocrine tumors (26) (27) . Obara and Takeda demonstrated that various types of epithelial and mesenchymal cells in the tooth germ express CD56 (15) . Er et al. reported that the outermost layer of the tumor nests in ameloblastomas also express CD56 (18) . In our study, we confirmed that CD56 was expressed in all cases of ameloblastoma. Of the 13 cases of odontogenic carcinoma examined here, 2 of 3 cases of ameloblastic carcinoma, and 1 case of PIOSCC were positive for CD56. None of our cases of gSCC showed immunoreactivity for CD56. These findings suggest that CD56 immunoreactivity might be involved not only in benign ameloblastoma but also in odontogenic carcinoma.
Calretinin, a calciumbinding protein with a molecular weight of 29 kDa, is a member of the large family of EFhand protein that also includes S-100 protein (28) (29) . Calretinin is widely expressed in central and peripheral neural tissues (28, 30) , normal and reactive mesothelial cells, eccrine glands of skin, convoluted tubules of kidney, Leydig and Sertoli cells of testis, endometrium and ovarian stromal cells, and adrenal cortical cells (3132). Calretinin expression has been used as one of the most specific and sensitive markers of malignant mesothelioma (33) . Several studies have also shown that calretinin is expressed, not only in the odontogenic epithelium in rat molar tooth germ (17) but also in human ameloblastomas (13-14, 16, 19 ), suggesting calretinin is a candidate for identifying tissues of odontogenic origin. In our study, we confirmed that calretinin immunoreactivity was observed in the stellate reticulum-like structures and in the inner squamous metaplastic cells of ameloblastoma, as previously reported (13) (14) 19) . However, all our cases of ameloblastic carcinoma and PIOSCC were negative for calretinin. Only a single GCOC case was positive for calretinin. Among the 30 cases of gSCC, 3 cases (10%) of poorly differentiated SCC were positive for calretinin. Although calretinin has been reported as a useful immunohistochemical marker for ameloblastoma ( 16, 19) , it was not expressed in the ameloblastic carcinoma which is a malignant counterpart of ameloblastoma, and was not expressed in PIOSCC.
In conclusion, we investigated the immunohistochemical characteristics of 13 cases of odontogenic carcinoma. Immunohistochemical studies indicated that CK19 is a useful immunohistochemical marker for identifying the odontogenic origin of odontogenic carcinomas, including PIOSCC, and that it might be useful for distinguishing PIOSCC from gSCC. CD56 may be a marker for odontogenic carcinoma as well as for benign ameloblastoma.
